Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 17c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($1.13), $0.17 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $7.05 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• PHINIA Inc. (PHIN) Reports Q1 EPS of $1.08, provides guidance
• Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
• Grainger (GWW) Tops Q1 EPS by 2c, provides guidance